All News


 

2021

May

Media Release / May 12, 2021

A first in Canada: generic version of pirfenidone

Read More

April

Media Release / Apr 27, 2021

Novartis Q1 2021 Financial Results

Read More
Media Release / Apr 21, 2021

New biosimilar switch policy in New Brunswick improves patient access to safe and effective medicines

Read More
Media Release / Apr 09, 2021

Finalist at Les Mercuriades

Read More

February

Media Release / Feb 16, 2021

Sandoz Canada completes its 5th biosimilar launch with new biosimilar Hyrimoz® (adalimumab)

Read More

January

Media Release / Jan 26, 2021

Sandoz Canada launches the first generic versions of two original drugs: PrSandoz® Posaconazole and PrSandoz® Silodosin

Read More
Media Release / Jan 26, 2021

Novartis 2020 Financial Results

Read More
2020

December

Media Release / Dec 17, 2020

Sandoz Canada receives authorization from Health Canada to launch new biosimilar Hyrimoz® (adalimumab)

Read More

August

Media Release / Aug 19, 2020

Sandoz Canada launches two new biosimilars Ziextenzo® and Riximyo®

Read More

July

Media Release / Jul 16, 2020

Novartis in Canada certified as a Great Place to Work® for a second consecutive year

Read More